BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY NIELSINE NIELSEN
The wealthy and highly lucrative medtech firm Coloplast needs to let go of some of its caution, release the billions and acquire either new firms or technology, according to several industry actors.
"If your strategy involves acquisitions, you have to acquire. Just like if your strategy is to be a digital frontrunner or to be best at marketing. You have to invest in your strategy," says ABG Sundal Collier Jannick Lindegaard Denholt. He is far from alone in his views:
Already a subscriber? Log in.
Read the whole article
Get 14 days free access.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Hearing firms urge FDA to increase OTC safety requirements
A number of the world’s biggest hearing aid manufacturers have come together to encourage the US health authority to tighten the safety requirements for OTC hearing aids, which will hit the shelves in the US sometime this year.
Novo Nordisk launches oral semaglutide in India
Novo Nordisk’s diabetes drug, semaglutide, will be sold in the country in a similar price range as its injectable version.
Coloplast initiates trial of ostomy leakage product
The medtech company will being clinically testing its ostomy add-on product, Heylo, in January.
Top news from MedWatch this week
Miss anything?
Danish bank cuts Genmab price target, retains "buy" recommendation
Jyske Bank has adjusted its valuation of Genmab’s share price target to DKK 2850 (USD 434.4). Investors should continue to buy, the Danish bank says.
Principal Scientist 
Clinical Research Associate 
Senior Director, Global Regulatory Lead 
Senior HR Director, HR Denmark, Ferring 
Medical Director, Translational Medicine 
GxP QA Compliance Manager for Quality Assurance 
NORDIC Medical Sales Director 
Associate Director, Tax 
Health Economist 
Director Medical Science 
Chemists are wanted for ALK's internal Aircraft Corps 
KLIFO is looking for a Director, Business Support for our Glostrup office 
Senior Key Account Manager 
QA Manager GMP/GDP Compliance & Audits